Literature DB >> 11574918

Population-based incidence and characteristics of community-onset Staphylococcus aureus infections with bacteremia in 4 metropolitan Connecticut areas, 1998.

C A Morin1, J L Hadler.   

Abstract

This study retrospectively analyzed the magnitude and epidemiology of community-onset Staphylococcus aureus (COSA) infections and methicillin-resistant S. aureus (MRSA) infections in 4 Connecticut metropolitan areas (population, 1.1 million). The study looked at hospital medical records of persons admitted with S. aureus bacteremia in 1998. COSA was categorized as "health care associated," "with underlying medical condition," or "no underlying medical condition." Overall, 48% of S. aureus bacteremic infections were COSA (incidence, 17 cases/100,000 persons). Incidence increased with age and higher population density. In all, 62% of infections were health care associated; 85% of the remaining cases had underlying medical conditions. MRSA accounted for 16% of health care-associated cases and cases with underlying conditions but no cases with no underlying conditions. COSA bacteremic infections are as common as those due to pneumococci. MRSA is a well-established cause of COSA among persons at high medical risk for S. aureus infection. Additional study to understand community-onset MRSA acquisition is needed.

Entities:  

Mesh:

Year:  2001        PMID: 11574918     DOI: 10.1086/323459

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  51 in total

1.  MRSA bacteraemia in patients on arrival in hospital: a cohort study in Oxfordshire 1997-2003.

Authors:  David H Wyllie; Tim E A Peto; Derrick Crook
Journal:  BMJ       Date:  2005-09-09

2.  Phase I dose escalation study to evaluate the safety and pharmacokinetic profile of tefibazumab in subjects with end-stage renal disease requiring hemodialysis.

Authors:  Seth Hetherington; Michele Texter; Eric Wenzel; Joseph M Patti; Laurie Reynolds; Trish Shamp; Suzanne Swan
Journal:  Antimicrob Agents Chemother       Date:  2006-10       Impact factor: 5.191

3.  Staphylococcus aureus: The persistent pathogen.

Authors:  B Lynn Johnston; John M Conly
Journal:  Can J Infect Dis       Date:  2003-11

4.  Healthcare-associated pneumonia: where do we go next?

Authors:  Marcos I Restrepo; Stefano Aliberti
Journal:  Clin Infect Dis       Date:  2013-11-22       Impact factor: 9.079

5.  Phase II, randomized, double-blind, multicenter study comparing the safety and pharmacokinetics of tefibazumab to placebo for treatment of Staphylococcus aureus bacteremia.

Authors:  J John Weems; James P Steinberg; Scott Filler; John W Baddley; G Ralph Corey; Priya Sampathkumar; Lisa Winston; Joseph F John; Christine J Kubin; Rohit Talwani; Thomas Moore; Joseph M Patti; Seth Hetherington; Michele Texter; Eric Wenzel; Violet A Kelley; Vance G Fowler
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

6.  Direct detection of methicillin resistance in Staphylococcus aureus in blood culture broth by use of a penicillin binding protein 2a latex agglutination test.

Authors:  Qinfang Qian; Lata Venkataraman; James E Kirby; Howard S Gold; Toshiaki Yamazumi
Journal:  J Clin Microbiol       Date:  2010-02-03       Impact factor: 5.948

7.  Trends and characteristics of culture-confirmed Staphylococcus aureus infections in a large U.S. integrated health care organization.

Authors:  G Thomas Ray; Jose A Suaya; Roger Baxter
Journal:  J Clin Microbiol       Date:  2012-03-14       Impact factor: 5.948

8.  Population-based risk factors for community-onset bloodstream infections.

Authors:  Kevin B Laupland; Kelsey Pasquill; Gabrielle Dagasso; Elizabeth C Parfitt; Lisa Steele; Henrik C Schonheyder
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-12-19       Impact factor: 3.267

9.  Molecular analysis of Staphylococcus aureus blood isolates shows lack of polyclonal bacteremia.

Authors:  Riad Khatib; Mamta Sharma; S Anwar H Naqvi; Kathleen Riederer; Mohammed O Almoujahed; Mohamad G Fakih
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

10.  Community-associated methicillin-resistant Staphylococcus aureus: trends in case and isolate characteristics from six years of prospective surveillance.

Authors:  Kathryn Como-Sabetti; Kathleen H Harriman; Jessica M Buck; Anita Glennen; David J Boxrud; Ruth Lynfield
Journal:  Public Health Rep       Date:  2009 May-Jun       Impact factor: 2.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.